BTIG raised the firm’s price target on Upwork (UPWK) to $18 from $16 and keeps a Buy rating on the shares as part of a broader research note ...

BTIG analyst Marvin Fong raised the firm’s price target on Cars.com (CARS) to $25 from $23 and keeps a Buy rating on the shares as part of a ...

BTIG Maintains Neutral Snap Thesis Ahead Of Q2 Report, But 'Patience Is Wearing Thin' BTIG Raises Facebook Price Target By More Than 50%, Says Instagram Becoming 'Most Powerful, Valuable Mall In ...

Fintel reports that on December 2, 2024, BTIG initiated coverage of BrightView Holdings (NYSE:BV) with a Buy recommendation.

Fintel reports that on December 2, 2024, BTIG downgraded their outlook for AnaptysBio (NasdaqGS:ANAB) from Buy to Neutral.

Tech was leading the way lower for stocks Wednesday. BTIG Chief Market Technician Jonathan Krinsky noted that while tech ...

AnaptysBio (NASDAQ:ANAB – Get Free Report) was downgraded by investment analysts at BTIG Research from a “buy” rating to a “neutral” rating in a research report issued on Monday, MarketBeat reports.

NEW YORK--(BUSINESS WIRE)--BTIG announced today that its Digital Health Forum will take place on Monday, November 25, 2024. The event will be hosted by David Larsen, CFA, BTIG Healthcare IT and ...

On Friday, BTIG adjusted its stance on Outlook Therapeutics Inc. (NASDAQ: NASDAQ:OTLK), reducing the price target significantly to $9.00 from the previous $50.00, while still retaining a Buy rating on ...

Investors should start looking at restaurant names that have timely setups, said Jonathan Krinsky, chief market technician at BTIG, in a note. “Brinker International (EAT) is not in the S&P 500 ...

BTIG lowered the firm’s price target on Outlook Therapeutics (OTLK) to $9 from $50 and keeps a Buy rating on the shares. The firm says ONS-5010 did not surpass the 95% threshold for the primary ...